Source: Global Legal Chronicle

Evolve Biosystems: Evolve BioSystems' $55 Million Series D Financing

Morrison & Foerster LLP advised Evolve BioSystems Inc. on the deal. Evolve BioSystems Inc. announced its $55 million Series D financing co-led by Cargill Inc., a global [...]

Read full article »

Evolve Biosystems's Competitors | Evolve Biosystems's News | Evolve Biosystems's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

CEO

Update CEO

CEO Approval Rating

- -/100

Evolve Biosystems is a California-based biotechnology firm that develops and commercializes microbiome-based therapeutics for the treatment of infant gut health problems.